Sk Biopharmaceutica (Korea) Buy Hold or Sell Recommendation
| 326030 Stock | 102,100 1,500 1.45% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Sk Biopharmaceuticals Co is 'Strong Sell'. Macroaxis provides Sk Biopharmaceutica buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 326030 positions.
Check out Sk Biopharmaceutica Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as 326030 and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Sk Biopharmaceuticals Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
326030 |
Execute Sk Biopharmaceutica Buy or Sell Advice
The 326030 recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Sk Biopharmaceuticals Co. Macroaxis does not own or have any residual interests in Sk Biopharmaceuticals Co or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Sk Biopharmaceutica's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Sk Biopharmaceutica Trading Alerts and Improvement Suggestions
| Sk Biopharmaceutica generated a negative expected return over the last 90 days | |
| Sk Biopharmaceutica generates negative cash flow from operations | |
| About 64.0% of the company shares are owned by insiders or employees |
Sk Biopharmaceutica Returns Distribution Density
The distribution of Sk Biopharmaceutica's historical returns is an attempt to chart the uncertainty of Sk Biopharmaceutica's future price movements. The chart of the probability distribution of Sk Biopharmaceutica daily returns describes the distribution of returns around its average expected value. We use Sk Biopharmaceuticals Co price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Sk Biopharmaceutica returns is essential to provide solid investment advice for Sk Biopharmaceutica.
| Mean Return | 0.02 | Value At Risk | -4.17 | Potential Upside | 5.77 | Standard Deviation | 2.90 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Sk Biopharmaceutica historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Sk Biopharmaceutica Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Sk Biopharmaceutica or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Sk Biopharmaceutica's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a 326030 stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | -0.04 | |
σ | Overall volatility | 2.92 | |
Ir | Information ratio | -0.0026 |
Sk Biopharmaceutica Volatility Alert
Sk Biopharmaceuticals Co currently demonstrates below-average downside deviation. It has Information Ratio of 0.0 and Jensen Alpha of 0.02. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Sk Biopharmaceutica's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Sk Biopharmaceutica's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Sk Biopharmaceutica Fundamentals Vs Peers
Comparing Sk Biopharmaceutica's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Sk Biopharmaceutica's direct or indirect competition across all of the common fundamentals between Sk Biopharmaceutica and the related equities. This way, we can detect undervalued stocks with similar characteristics as Sk Biopharmaceutica or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Sk Biopharmaceutica's fundamental indicators could also be used in its relative valuation, which is a method of valuing Sk Biopharmaceutica by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Sk Biopharmaceutica to competition |
| Fundamentals | Sk Biopharmaceutica | Peer Average |
| Return On Equity | -0.12 | -0.31 |
| Return On Asset | 0.0475 | -0.14 |
| Profit Margin | (0.12) % | (1.27) % |
| Operating Margin | 0.11 % | (5.51) % |
| Current Valuation | 5.87 T | 16.62 B |
| Shares Outstanding | 78.31 M | 571.82 M |
| Shares Owned By Insiders | 64.28 % | 10.09 % |
| Shares Owned By Institutions | 5.26 % | 39.21 % |
| Price To Book | 15.89 X | 9.51 X |
| Price To Sales | 13.94 X | 11.42 X |
| Revenue | 418.64 B | 9.43 B |
| Gross Profit | 396.31 B | 27.38 B |
| EBITDA | 83.87 B | 3.9 B |
| Net Income | 64.85 B | 570.98 M |
| Cash Flow From Operations | (92.87 B) | 971.22 M |
| Earnings Per Share | (117.74) X | 3.12 X |
| Target Price | 96154.0 | |
| Number Of Employees | 10 | 18.84 K |
| Beta | 1.11 | -0.15 |
| Market Capitalization | 5.32 T | 19.03 B |
| Total Asset | 643.65 B | 29.47 B |
| Net Asset | 643.65 B |
Sk Biopharmaceutica Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as 326030 . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0376 | |||
| Daily Balance Of Power | (0.38) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 101650.0 | |||
| Day Typical Price | 101800.0 | |||
| Market Facilitation Index | 3900.0 | |||
| Price Action Indicator | (300.00) | |||
| Period Momentum Indicator | (1,500) | |||
| Relative Strength Index | 50.73 |
About Sk Biopharmaceutica Buy or Sell Advice
When is the right time to buy or sell Sk Biopharmaceuticals Co? Buying financial instruments such as 326030 Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Sk Biopharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Oil And Gas Thematic Idea Now
Oil And Gas
Companies involved in drilling, production, and distribution of oil and gas pipelines. The Oil And Gas theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Oil And Gas Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in 326030 Stock
Sk Biopharmaceutica financial ratios help investors to determine whether 326030 Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 326030 with respect to the benefits of owning Sk Biopharmaceutica security.